Direxion has filed for effectiveness on 92 new exchange-traded funds (ETFs), expanding its offerings significantly. The new filings include a variety of leveraged single stock products and other highly concentrated ETFs with exposure to approximately five stocks each. This move highlights Direxion's strategy to cater to investors seeking targeted and leveraged exposure in the stock market.
Direxion Files for 92 New ETFs, Including Leveraged Single Stock Products
Disclaimer: The content provided on Phemex News is for informational purposes only. We do not guarantee the quality, accuracy, or completeness of the information sourced from third-party articles. The content on this page does not constitute financial or investment advice. We strongly encourage you to conduct you own research and consult with a qualified financial advisor before making any investment decisions.
